8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Sci Rep 13(1):17806, 2023

Bioeffects Seen

Authors not listed · 2023

Share:

Gold nanoparticles activated by near-infrared light successfully crossed the blood-brain barrier to kill brain cancer cells in mice.

Plain English Summary

Summary written for general audiences

Researchers developed gold-based nanoparticles that use near-infrared light to trigger a specific type of cell death called ferroptosis in brain cancer cells. The study found these particles could cross the blood-brain barrier and selectively target glioblastoma tumors while extending survival time in mice. This represents a new approach to treating aggressive brain cancers using light-activated therapy.

Why This Matters

While this study focuses on therapeutic applications rather than EMF health risks, it highlights an important principle we see throughout EMF research: electromagnetic energy can trigger specific biological pathways at the cellular level. The researchers used near-infrared radiation to activate gold nanoparticles that then induced ferroptosis, a form of programmed cell death. This demonstrates how non-ionizing electromagnetic frequencies can produce measurable biological effects when targeted appropriately. The study's success in crossing the blood-brain barrier and affecting brain cells also reinforces what we know about EMF's ability to influence neural tissue. What makes this particularly relevant to the EMF health debate is that it shows how specific frequencies can be engineered to produce desired biological outcomes, which raises questions about what unintended effects other electromagnetic exposures might be having on our cells.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2023). Sci Rep 13(1):17806, 2023.
Show BibTeX
@article{sci_rep_13117806_2023_ce3847,
  author = {Unknown},
  title = {Sci Rep 13(1):17806, 2023},
  year = {2023},
  doi = {10.1002/advs.202206333},
  
}
DOI: 10.1002/advs.202206333PubMed: 36869410

Quick Questions About This Study

Yes, this study demonstrated that near-infrared-II light can successfully activate gold-based nanoparticles that crossed the blood-brain barrier. The activated particles then triggered ferroptosis, a specific type of cell death, in glioblastoma tumor cells while extending survival time in mice.
Ferroptosis is a form of programmed cell death involving iron-dependent lipid damage. The study found that gold(I) particles specifically activated heme oxygenase-1, an enzyme that regulates ferroptosis in glioma cells, offering a new mechanism for targeted cancer treatment.
The research confirmed that these specially designed gold nanoparticles (TBTP-Au NPs) successfully penetrated the blood-brain barrier and reached brain tumor sites. The study achieved real-time visual monitoring of both barrier penetration and tumor targeting processes.
The researchers suggest gold may be safer because it's an essential cofactor for life and can specifically bind to tumor cells, potentially reducing undesired effects on normal cells compared to iron-based systems that might trigger nonspecific activations.
This study showed promising results for treating glioblastoma, an aggressive brain cancer. The light-activated gold nanoparticles significantly extended survival time in mice by specifically targeting tumor cells while allowing real-time monitoring of treatment progress.